NasdaqGS:CAPRBiotechs
Assessing Capricor Therapeutics (CAPR) Valuation After Strong Multi Year Gains And Recent Share Price Pullback
Capricor Therapeutics overview and recent share performance
Capricor Therapeutics (CAPR) has drawn fresh attention after recent trading left the stock at a last close of US$30.33, with performance mixed over shorter periods but very strong over the past year and multi year window.
Over the past day the share price declined 3.8%, and over the past week it fell about 11.8%. The stock is also down roughly 12.2% over the past month, while remaining up 28.1% over the past 3 months.
Looking at...